✦ LIBER ✦

Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine

✍ Scribed by Patricia M. Egan; Mary T. Belfast; Juan A. Giménez; Robert D. Sitrin; Ralph J. Mancinelli

Book ID: 116961515
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 412 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.03.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an adjuvant

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

✍ CHIEW TONG, NORELLA KONG; BERAN, JIRI; KEE, SWEE ANN; MIGUEL, JOSE LUIS; SÁNCHEZ 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Immunogenicity and safety of an experime

Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients

✍ Frederik Nevens; Jane N. Zuckerman; Andrew K. Burroughs; Maria-Christina Jung; J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Patients with chronic liver disease are at higher risk of hepatitis B (HB) virus infection before and after liver transplantation, and they commonly have a suboptimal immune response to HB vaccines. In this randomized trial, we compared the immunogenicity of primary vaccination with 2 doses of an ex

Immunogenicity and safety of an investig

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

✍ Janssen, Robert S.; Mangoo-Karim, Roberto; Pergola, Pablo E.; Girndt, Matthias; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 961 KB

Immunogenicity and safety of an investig

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age

✍ Heyward, William L.; Kyle, Michael; Blumenau, Joseph; Davis, Matthew; Reisinger, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Immunogenicity and safety of an investig

Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials

✍ Christian L. Tielemans; Jiri Vlasak; Dezider Kosa; Jean-Marie Billiouw; Gert A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 249 KB